Effects, Tolerance, and Response to COVID-19 Vaccines in Hispanic Puerto Rican Patients with Multiple Sclerosis
Background: At the start of the SARS-CoV-2 (COVID-19) pandemic there was uncertainty among Multiple Sclerosis (MS) patients about starting...
Adherence to Oral Disease Modifying Therapies in Clinical Practice and Patient-Centered Outcomes
Background: There are more than 20 disease modifying therapies (DMTs) approved for treatment of Multiple Sclerosis. Previous studies in the...
Longitudinal Olfactory Patterns in Multiple Sclerosis: A Scoping Review and Implications for Use in Management of Disease
Background: Previous studies reviewing the presence of olfactory dysfunction (OD) in Multiple Sclerosis (MS) have focused on the prevalence...
Oligoclonal Band Negative Multiple Sclerosis in Puerto Rico
Background: The incidence of multiple sclerosis (MS) in Puerto Rico (PR) is higher than in other Latin American and Caribbean countries....
Demographic and Clinical Associations with Neuromyelitis Optica Spectrum Disorder in an Academic Medical Center
Background: Neuromyelitis Optica Spectrum Disorder (NMOSD) is a rare, inflammatory CNS syndrome, which, left untreated, may result in...
Importance of Cervical Magnetic Resonance Imaging in the Diagnosis, Treatment, and Monitoring of Hispanic Puerto Rican Multiple Sclerosis Patients
Background: Some Health Insurances in Puerto Rico (PR) limit the number of magnetic resonance imaging (MRI) procedures that can be done in...
Evidence of Distress By Multiple Sclerosis (MS) Patient Caregiver As a Consequence of COVID-19
Background: Multiple Sclerosis (MS) is a demyelinating condition that leads to progressive weakness and disability often resulting in...